Results 11 to 20 of about 28,966 (201)
The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis. [PDF]
, 2018 BackgroundThe extent of coronary artery calcium (CAC) improves cardiovascular disease (CVD) risk prediction. The association between common dyslipidemias (combined hyperlipidemia, simple hypercholesterolemia, metabolic Syndrome (MetS), isolated low high ...
Abd Alamir, Moshrik +7 more
core +4 more sources
Statins and non-alcoholic fatty liver disease [PDF]
, 2019 Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico, F +3 more
core +1 more source
Treatment of dyslipidemia [PDF]
F1000Prime Reports, 2014 Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Allison Ruth Byrnes +1 more
openaire +3 more sources
Management options in the sudden hearing loss of a diabetic patient [PDF]
, 2019 The aim of our paper is to highlight the main therapeutic principles and the management options in the case of a diabetic patient who has had a sudden hearing loss.
Badiu, Dumitru Cristinel +11 more
core +3 more sources
Effect of atorvastatin and metformin combination therapy in type 2 diabetic dyslipidemias [PDF]
, 2020 Background: Dyslipidaemia is a major risk factor for cardiovascular complications in patients with type 2 diabetes mellitus and affects 10-73% of this population.
Saman, Ramsha, Voila, Margaret
core +2 more sources
Adipose Tissue Complexities in Dyslipidemias [PDF]
, 2019 Adipose tissue is the largest organ in the human body and, in excess, contributes to dyslipidemias and the dysregulation of other vascular and metabolic processes.
Gustafson, Deborah R.
core +2 more sources
Psoriasis and Dyslipidemia [PDF]
Materia Socio Medica, 2015 Psoriasis is a chronic skin ailment, which can be connected with other ailments including dyslipidemia.Research included 70 patients affected by psoriasis. Both genders, above 18 years of age. Average age of the respondents was 47.14 (SD= ±15.41), which consisted of 36 men (51.43%) and 34 women (48.57%). The average duration of psoriasis was 15.52 (SD=
Alma Handanagic +7 more
openaire +2 more sources
APOE genotypes and dyslipidemias in a sample of the Portuguese population [PDF]
, 2005 The objective of this work was to study the distribution of apolipoprotein E (APOE) genotypes in a sample of the Portuguese population, and its association with the dyslipidemias observed.
Albergaria, I. +6 more
core +1 more source
Mixed dyslipidemias in primary care patients in France [PDF]
, 2012 Laurent Laforest1, Baishali M Ambegaonkar2, Thierry Souchet3, Vasilisa Sazonov2, Eric Van Ganse11Lyon University, Lyon, France; 2Merck and Co Inc, Whitehouse Station, NJ, USA; 3Merck, Sharp & Dohme, Paris, FranceObjective: To determine the ...
Ambegaonkar, Baishali M +4 more
core +4 more sources
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism [PDF]
Endocrine Connections, 2022 Hypothyroidism is often associated with elevated serum levels of total cholesterol, LDL-C and triglycerides. Thyroid hormone (TH) affects the production, clearance and transformation of cholesterol, but current research shows that thyroid-stimulating hormone (TSH) also participates in lipid metabolism independently of TH.
Huixing Liu, Daoquan Peng
openaire +2 more sources